Skip to content

Efficacy of laser in facial rejuvination

Efficacy and side effects of Nd:YAG versus fractional Er:YAG in facial rejuvination

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015120320468N3
Enrollment
35
Registered
2016-04-03
Start date
2016-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Rejuvination. Other specified disorders of skin and subcutaneous tissue

Interventions

Intervention 1: Topical anesthetic gel is applied to both sides of face and left for 30minutes. The patient's eyes are covered with a shield during the entire procedure. Patients are randomly assigned
which is focused to a spot size of approximately 5-10 micrometer in diameter ,the pulse duration of 0.3 -20 milliseconds and fluence from 10 to 25 J/cm2.Three treatment sessions with 1 month interval
Topical anesthetic gel is applied to both sides of face and left for 30minutes. The patient's eyes are covered with a shield during the entire procedure. Patients are randomly assigned to receive trea

Sponsors

Skin Research Center, Shahid Beheshti University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:females between 35 and 75years of age ;patients with mild to moderate facial rhytides at rest Exclusion criteria :males;females younger than 35 yerars old;pregnancy and lactatation;cosmetic procedures affecting the treatment area (e.g.,botulinum toxin,dermabrasion, chemical peeling, laser surgery, or face-lift)within the last 6months;oral isotretinoin within the last 6months; history of keloid formation,connective tissue disorders,major underlying disease,diabetes, uncontrolled hypertension, active infection in face area, personal history of skin cancer in face,unrealistic expectation,sensitivity to tetracaine or lidocaine

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Skin Elasticiy. Timepoint: before intervention,before each laser sessions,3 months after last laser. Method of measurement: resonance running time/reviscometer.;Improvement of facial rythides. Timepoint: before intervention,before each laser sessions,3 months after last laser. Method of measurement: rate of improvement measured by comparing photograph by a dermatologist.;Patient satisfaction. Timepoint: 1month after session 1&2-three month after session3. Method of measurement: questionare.

Secondary

MeasureTime frame
?Duration of side effects. Timepoint: one week after each session. Method of measurement: number of days.;Side effects(pain-burning and stinging-erythem-edema-bulla-bleeding-crust formation-hypopigmentation-hyperpigmentation-scar-atrophy). Timepoint: one week after each session. Method of measurement: patient questionnaire,examination by a dermatologist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahar.dadkhahfar@gmail.com

Skin Research Center

sahar.dadkhahfar@gmail.com+98 21 4465 3272

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 5, 2026